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Introduction: Measurement of hormones and interpretation of endocrinological test results are 
more complex and challenging than measuring and interpreting the results of other routine 
biochemical analytes (e.g. urea, albumin). The methodologies employed for measuring 
hormones are, in their vast majority, immunoassays which were originally developed for 
measuring human hormones and have undergone validation for use in cats. The technically 
demanding nature of such methodologies is reflected by the very low number of available 
point-of-care tests for measuring hormones in comparison to the relatively high number of 
point-of care and bench-top analysers available for performing routine biochemical analyses 
in general practice. 
The most common endocrinopathies in feline clinical practice are hyperthyroidism and 
diabetes mellitus. Even on the rare occasions where two endocrinopathies are present in the 
same patient, hyperthyroidism and concurrent diabetes mellitus are most frequently 
diagnosed (Blois et al 2010). This lecture will focus on the hormones most commonly 
measured in general practice for the diagnosis of and monitoring treatment of these two 
endocrinopathies (T4, free T4, TSH, IGF-1). 
HYPERTHYROIDISM 
Serum total T4: Almost 95% of hyperthyroid cats can be diagnosed by a single high total T4 
result. Practitioners should know which assay is used in their in-house or external commercial 
veterinary laboratory. Serum T4 can be measured by i) a radioimmunoassay (RIA) (not 
commonly used any more), ii) automated immunoassays employed by commercial 
laboratories (e.g., Immulite®) and iii) an ELISA test kit or bench-top immunoassay analyser 
for in-house use (Kemppainen and Bitchfield 2006, Higgs et al 2014).  Although the 
correlation of serum T4 concentrations between all of these assay methods is generally good, 
the generated results cannot be used interchangeably and assay specific reference intervals 
should always be used. If a high serum T4 value is generated by an in-house assay in a cat 
without clinical signs of hyperthyroidism (especially without a palpable thyroid nodule) the 
test should be repeated in an external laboratory.  
Serum total T4 is the preferred screening test for hyperthyroidism but almost 10% of all 
hyperthyroid cats (and up to 40% of cats with early or mild hyperthyroidism) have serum T4 
results within (middle to top end) of the reference interval; the most common explanations 
are fluctuations of T4 and/or concurrent severe non-thyroidal illness suppressing mildly 
increased values to the middle or top end of the reference interval. In such cases the next 
laboratory investigation is to repeat T4 in two weeks, measure free T4 or TSH, or perform 
thyroid function tests. 
Serum free T4 (fT4): Serum fT4 concentrations are commonly measured by equilibrium 
dialysis and are elevated in more than 98% of hyperthyroid cats. However, the specificity of 
this test is questionable as it has been reported that 20% -30% of sick euthyroid cats, with 
total T4 values in the low end or below the reference interval, have increased fT4 results. 
Recently, many commercial veterinary diagnostic laboratories started employing fT4 assays 
which do not use equilibrium dialysis, as the importance of this analytical step and its 
diagnostic accuracy has been questioned after generating high numbers of false positive 
results. For this reason fT4 should not be used as a single test for the diagnosis of 
hyperthyroidism but in combination with total T4 and clinical findings. 
Serum Thyroid Stimulating Hormone (TSH): TSH will be suppressed in early stages of 
hyperthyroidism before total T4 values are increased. It has be shown that feline TSH can be 
measured by a widely available canine TSH chemiluminescence immunoassay as a feline 
specific assay has not been developed. It has been reported that the diagnostic specificity of 
this test is poor as up to 30% of older, euthyroid, cats can have undetectable serum TSH 
concentrations; this is because the low limit of the current canine immunoassay is not low 
enough to distinguish between the low-normal serum TSH in some euthyroid cats from the 
truly low (totally suppressed) concentrations of most hyperthyroid cats. However, 
measurement of TSH has a high sensitivity (98%) and can be used to rule-out the disease as a 
cat with a result within the reference interval is highly unlikely to have hyperthyroidism. 
DIABETES MELLITUS 
Serum total insulin-like growth factor-1 (IGF-1): Most practitioners perform measurement of 
IGF-1 as a screening test for acromegaly (hypersomatotropism) in diabetic cats as it has been 
suggested to be the underlying cause of diabetes mellitus in 24-32% of diabetic cats. 
However, false-negative results can occur as hepatic IGF-1 production is dependent on 
sufficient portal insulin, which can be deficient in newly diagnosed diabetic cats. In contrast, 
increased concentrations of IGF-1 have been reported in non-acromegalic diabetic cats. 
Currently measurement of feline IGF-1 is performed using radioimmunoassays which have 
inherent disadvantages (radioactive substances, restricted access, relatively high costs, 
variable assay performance). Recently the validation of an easy-to use and economical IGF-1 
ELISA revealed that this assay had a high diagnostic accuracy for detecting 
hypersomatotropism in diabetic cats (sensitivity 100%, specificity 88%) (Rosca et al 2014).  
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